UNSPSC 51285601: Azacosterol

This classification denotes an anti-lipidemic agent with the molecular formula C25H44N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EPT876J73A, chemically known as 20,25-diazacholesterol but more generally known as azacosterol, which bears US NIH Compound Identifier 9402. Azacosterol most often comes in base, dihydrochloride, and hydrochloride forms. European Medicines Agency schedules Azacosterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05627MIG.

UNSPSC 51285601 Azacosterol is a Commodity code that captures pharmaceutical products and active pharmaceutical ingredients procured by state and local health agencies. Recent state and local opportunities tagged under this code show procurement of antibiotic tablets, opioid antagonists, and drug deactivation systems — indicating that the code encompasses a broader range of pharmaceutical supplies than the specific sterol compound its name suggests. State and local buyers using this code include state departments of public health and county health authorities. These agencies source pharmaceutical inventory through both direct procurement and cooperative purchasing vehicles such as the MMCAP Infuse consortium, which aggregates buying power across multiple jurisdictions and enables smaller health departments to access negotiated pharmaceutical contracts.

Activity under the code appears concentrated in Illinois and Florida, with the Illinois Department of Public Health executing a $2,999,999.11 award to Chartwell Rx LLC through MMCAP Infuse for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets on August 28, 2026 (Invitation for Bid 26482DPHPREPDB53392, completed award), and Seminole County, Florida releasing an IFB (60459723LAS) on June 30, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a July 26, 2023 response deadline. Both procurements employ competitive bidding and include requirements for drug-free workplace certification and E-Verify compliance. The Seminole County procurement specified quarterly deliveries and included potential FEMA funding with attendant federal compliance obligations.